References
1. Burneo JG, McLachlan RS. When should surgery be considered for the treatment of epilepsy? CMAJ 2005; 172(9):1175–7.4
2. N. Aydemir, C. Ozkara, R. Canbeyli and A. Tekcan, “Changes in Quality of Life and Self-Perspective Related to Surgery in Patients with Temporal Lobe Epilepsy,” Epilepsy & Behavior, Vol. 5, No. 5, 2004, pp. 735-742.
3. M. D. Turner and R. S. Glickman, “Epilepsy in the Oral and Maxillofacial Patient: Current Therapy,” Journal of Oral and Maxillofacial Surgery, Vol. 63, No. 7, 2005, pp. 996-1005.
4. T. R. Browne and G. L. Holmes, “Epilepsy,” New Eng-land Journal of Medicine, Vol. 344, No. 15, 2001, pp. 1145-1151.
5. P. J. Chapman, “Medical Emergencies in Dental Practice and Choice of Emergency Drugs and Equipment: A Sur-vey of Australien Dentists,” Australian Dental Journal, Vol. 42, No. 2, 1997, pp. 103-108.
6. H. Friedlander and J. L. Cummings, “Temporal Lobe Epilepsy: Its Association with Psychiatric Impairment and Appropriate Dental Management,” Oral Surgery, Oral Medicine, Oral Pathology, Vol. 68, No. 3, 1989, pp. 288-292.
7. G. V. Busschots and B. I. Milzman, “Dental Patients with Neurologic and Psychiatric Concerns,” Dental Clinics of North America, Vol. 43, 1999, pp. 471-483.
8. Karolyhazy K, Kovacs E, Kivovics P, Fejerdy P, Aranyi Z. Dental status and oral health of patients with epilepsy: an epidemiologic study. Epilepsia 2003; 44(8):1103–8.
9. Karolyhazy K, Kivovics P, Fejerdy P, Aranyi Z. Prosthodontic status and recommended care of patients with epilepsy. J Prosthet Dent 2005; 93(2):177–82.
10. Aragon CE, Burneo JG, Helman J. Occult maxillofacial trauma in epilepsy. J Contemp Dent Pract 2001; 2(4):26–32.19.
11. Mattson RH, Gidal BE. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 2004; 5(Suppl 2):S36–40.20
12. Goulden KJ, Dooley JM, Camfield PR, Fraser AD. Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 1987; 37(8):1392–4.30
DOI: http://dx.doi.org/10.18535/jmscr/v4i4.30
